INTerpath-001: Personalized mRNA Vaccine Improves Melanoma Outcomes | ESMO 2026

More on melanoma and skin cancers

Skin Cancer Beyond the Trials: Pregnancy & Transplant Recipients | ESMO26
Dr. Mario Balsa. Expert pick. ESMO 2026. Day 2.
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Publication pick. NEJM. October 9, 2026.

The OncoAlert Newsletter goes to 10,000+ oncologists and cancer stakeholders: every week, and every day during the major congresses. Free, independent, GDPR-compliant and easy to leave.

Email address

Your role

Your country

How we use your details

INTerpath-001: Personalized mRNA Vaccine Improves Melanoma Outcomes | ESMO 2026

More on melanoma and skin cancers

Skin Cancer Beyond the Trials: Pregnancy & Transplant Recipients | ESMO26

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

The week in oncology, in your inbox